1. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
    Muhammad Khan et al, 2021, Frontiers in Immunology CrossRef
  2. Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer
    Giulia Pasello et al, 2020, Cancer Treatment Reviews CrossRef
  3. Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis
    Qiyu Tang et al, 2023, Frontiers in Pharmacology CrossRef
  4. Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression
    Afsheen Raza et al, 2023, Frontiers in Immunology CrossRef
  5. Study of the clinicopathological features of soluble PD-L1 in lung cancer patients
    Takanobu Sasaki et al, 2023, Journal of Rural Medicine CrossRef
  6. Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
    Muhammad Khan et al, 2020, Frontiers in Immunology CrossRef
  7. Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
    Manuela Tiako Meyo et al, 2020, Cancers CrossRef
  8. Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
    Salum J. Lidenge et al, 2020, Cancers CrossRef
  9. Myeloid-Derived Suppressive Cells in Ageing and Age-Related Diseases
    Valquiria Bueno et al, 2022, Healthy Longevity and Immune System CrossRef
  10. Evolving Dynamic Biomarkers for Prediction of Immune Responses to Checkpoint Inhibitors in Cancer
    Afsheen Raza et al, 2021, Advances in Precision Medicine Oncology CrossRef
  11. Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis
    Yangyang Ding et al, 2023, Annals of Hematology CrossRef
  12. ІМУНОГІСТОХІМІЧНА ХАРАКТЕРИСТИКА ГІПЕРПЛАЗІЙ ЕНДОМЕТРІЯ ПОРІВНЯНО ІЗ СЕКРЕТОРНИМ ЕНДОМЕТРІЄМ
    D. A. Khaskhachikh et al, 2024, Актуальні питання педіатрії, акушерства та гінекології CrossRef